EVH · NYSE · Medical - Healthcare Information Services

Evolent (EVH)

Runs risk-based and fee-based specialty-care programs covering oncology, cardiology, and musculoskeletal conditions for health plans.

$3.78
After-hours close−0.01 (−0.26%)
At close$3.79(+2.71%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue511556640647621647484444480469496653
Cost of revenue387454536540541571381367404417434572
Gross profit12410210410781761027776526281
1421231189997941047475627290
Research & development770000000000
978179696747787475627269
General & administrative007900078000069
Other expenses39353830304726000022
Operating income−18−21−138−16−19−231−10−10−10
−13−27−3−6−7−5−62−24−21−421−16−16
Interest income133111111111
Interest expense15126667101216191717
Other non-operating income−214−311−151124402−1−1
Income before tax−31−48−171−24−24−63−21−20−431−26−26
Income tax expense−6−1510−1−11−11−213
Net income from continuing operations−25−33−172−23−23−65−20−21−429−27−28
Net income−25−33−172−23−23−65−20−21−429−27−28
EPS, basic−$0.30−$0.36−$0.22−$0.06−$0.27−$0.27−$0.63−$0.44−$0.24−$3.76−$0.24−$0.25
EPS, diluted−$0.30−$0.36−$0.22−$0.06−$0.27−$0.27−$0.63−$0.44−$0.24−$3.76−$0.24−$0.25
Weighted average shares, basic112114114115115115115116114114112113
Weighted average shares, diluted112114114115115115115116114114112113
EBITDA18−619361213−291523−3671413
Depreciation & amortization353030303030242427452222
EBIT−16−36−116−18−17−53−9−3−412−9−9